Clinical Trial

Brain Connectivity Analysis

Study acronym: Neurehab
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Stroke remains the leading cause of permanent disability. The neuromodulation technique of transcranial Direct Current Stimulation (tDCS) has the potential to serve as an adjuvant therapy to enhance neuronal connectivity following stroke. By combining electroencephalography (EEG) and tDCS, this study aims to investigate changes in network connectivity and cerebral plasticity, which are key factors in functional recovery after stroke. The objectives are to: 1) analyze how tDCS modulates neuronal activity, 2) evaluate persistent effects in follow-up assessments, and 3) predict patient outcomes. Studies on human subjects will be complemented by research in a mouse model of stroke to: 1) identify the molecular mechanisms underlying tDCS effects on functional recovery, 2) establish correlations among functional, molecular, and connectivity indices, and 3) assess the efficacy of biomimetic nanoparticles in targeting injured brain tissue to reduce inflammation, enhance neuronal plasticity, and support functional recovery.
Trial Details
NCT Number NCT06823102
Lead Sponsor IRCCS San Raffaele Roma
Conditions Neural Injury
Enrollment 75 participants
Start Date 2023-04-28
Primary Completion 2024-04-28 (estimated)
Study Completion 2026-04-27 (estimated)
Updated on ClinicalTrials.gov 2025-02-12